Jessica Tizen
Associate Director of Investor Relations
Replay available
ACADIA Pharmaceuticals Inc. (ACAD) Q2 2023 Earnings Call
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Q2 2023 earnings conference call, held 2023-08-02. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Steve Davis
Chief Executive Officer
Brendan Tien
Chief Operating Officer and Head of Commercial
Doug Williamson
Head of Research and Development
Mark Schneier
Chief Financial Officer
Tess Romero
JPM (Analyst)
Charles Duncan
Cancer Fitzgerald
Mark Goodman
LeRinc
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Acadia Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:04.322 Good day, ladies and gentlemen, and welcome to Arcadia Pharmaceuticals' second quarter 00:00:04.322 -- 00:00:09.516 2023 financial results conference call. My name is Jada, and I will be your coordinator 00:00:09.516 -- 00:00:13.379 for today. At this time, all participants are in a listen-only mode. 00:00:13.379 -- 00:00:17.903 We will be facilitating a question and answer session towards the end of today's call. 00:00:17.903 -- 00:00:22.146 If at any time during the call you require assistance, please press star followed by 00:00:22.146 -- 00:00:24.928 zero, and a coordinator will be happy to assist you. 00:00:24.928 -- 00:00:30.093 I would now like to turn the presentation over to Jessica Tizen, Associate Director 00:00:30.093 -- 00:00:34.994 of Investor Relations at Acadia. Please proceed. 00:00:36.437 -- 00:00:41.520 Thank you. Good afternoon and thank you for joining us on today's call to discuss Acadia's 00:00:41.520 -- 00:00:44.460 second quarter 2023 earnings. 00:00:44.622 -- 00:00:49.665 Joining me on the call today from Acadia are Steve Davis, our Chief Executive Officer, 00:00:49.665 -- 00:00:54.688 who will provide some opening remarks, followed by Brendan Tien, our Chief Operating 00:00:54.688 -- 00:01:00.012 Officer and Head of Commercial, who will discuss the debut launch and new plaza execution. 00:01:00.012 -- 00:01:04.233 Doug Williamson, our head of research and development, will provide an update on our 00:01:04.233 -- 00:01:09.376 pipeline programs, and Mark Schneier, our chief financial officer, will review the financial 00:01:09.376 -- 00:01:14.238 highlights. Steve will then provide some closing thoughts before we open the call up 00:01:14.238 -- 00:01:19.000 for your questions. In addition, Kathy Bishop, o...